User profiles for "author:A Finn"

Adam Finn

Professor of Paediatrics
Verified email at bristol.ac.uk
Cited by 30443

Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage

R Virmani, FD Kolodgie, AP Burke, AV Finn… - … , and vascular biology, 2005 - Am Heart Assoc
Observational studies of necrotic core progression identify intraplaque hemorrhage as a
critical factor in atherosclerotic plaque growth and destabilization. The rapid accumulation of …

Concept of vulnerable/unstable plaque

AV Finn, M Nakano, J Narula, FD Kolodgie… - … , and vascular biology, 2010 - Am Heart Assoc
Today's concept of vulnerable plaque has evolved primarily from the early pioneering work
uncovering the pivotal role of plaque rupture and coronary thrombosis as the major cause of …

The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes

FD Kolodgie, AP Burke, A Farb, HK Gold… - Current opinion in …, 2001 - journals.lww.com
While the concept of plaquevulnerability'implies a propensity towards thrombosis, the term
vulnerable was originally intended to provide a morphologic description consistent with …

[HTML][HTML] Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South …

…, L Fairlie, SN Faust, S Feng, DM Ferreira, A Finn… - The Lancet, 2021 - thelancet.com
Background A safe and efficacious vaccine against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control …

[HTML][HTML] Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled …

…, M Bittaye, EA Clutterbuck, C Dold, SN Faust, A Finn… - The Lancet, 2020 - thelancet.com
Background The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) might be curtailed by vaccination. We assessed the safety, reactogenicity, and …

[HTML][HTML] Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a …

…, L Fairlie, SN Faust, S Feng, DM Ferreira, A Finn… - The Lancet, 2021 - thelancet.com
Summary Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for
emergency use by the UK regulatory authority, Medicines and Healthcare products …

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk

M Joner, AV Finn, A Farb, EK Mont, FD Kolodgie… - Journal of the American …, 2006 - jacc.org
Objectives: This study examined human drug-eluting stents (DES) to determine the long-
term effects of these stents on coronary arterial healing and identified mechanisms …

[HTML][HTML] Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised …

…, AL Flaxman, SN Faust, DM Ferreira, S Feng, A Finn… - The Lancet, 2021 - thelancet.com
Background A new variant of SARS-CoV-2, B. 1.1. 7, emerged as the dominant cause of
COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the …

[HTML][HTML] Intraplaque hemorrhage and progression of coronary atheroma

FD Kolodgie, HK Gold, AP Burke… - … England Journal of …, 2003 - Mass Medical Soc
Background Intraplaque hemorrhage is common in advanced coronary atherosclerotic
lesions. The relation between hemorrhage and the vulnerability of plaque to disruption may …

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a …

…, T Dinesh, A England, SN Faust, DM Ferreira, A Finn… - The Lancet, 2021 - thelancet.com
Background Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate
mass COVID-19 immunisation. However, we have previously reported that heterologous …